Moderna’s Covid vaccine should be made available for children aged six to 17 years, an independent panel at the Food and Drug Administration said Tuesday — as America’s Covid wave fell on all fronts.
All 22 members of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted to approve the two-dose jab for the age group following an all-day debate on the issue.
The FDA is now expected to sign-off on the shots in the coming weeks. The Centers for Disease Control and…
